During this past granting period we completed the molecular cloning of both the gene and the cDNA encoding the human antidiuretic hormone or type 2 vasopressin receptor (V2R). The complete procedure entailed the construction of a series of stable transformant cell lines expressing the V2 receptor encoded in human genomic DNA in murine L cells. A lambda EMBL3 phage containing the complete V2R transcription unit was identified by expression in L cells. A fragment of the EMBL3 insert (V2R gene), was used to clone the V2R cDNA from the transformed L cell and from a human kidney cDNA library. Both cDNAs encode the same protein of 371 amino acids that is predicted to have seven transmembrane domains characteristic of G protein coupled receptors. The coding region of the gene is interrupted by two short introns. We located the gene to the q28-qter portion of the X chromosome, coincidental with the locus of congenital nephrogenic diabetes insipidus (CNDI). Analysis of the genomic DNA from CNDI patients revealed the presence of mutations in the region encoding the receptor protein.
The specific aims of the research proposed for the next five years are: l. To continue analyzing the mutations in V2R of newly identified families suffering CNDI. 2. To express the CNDI open reading frames (ORF) so as to determine which aspect of receptor function is altered: hormone binding and affinity, signal transduction, and receptor sequestration. As necessary studies on receptor targeting to the cell surface will be performed with epitope tagged receptors to evaluate the impact of cDNA modifications upon receptor protein expression. To investigate whether receptor sequestration can occur without phosphorylation. To complete the cloning of the human V1 receptor so as to construct V2R/V1R chimeras and delineate regions important for G protein coupling and receptor sequestration. 3. To identify the location of the extrarenal site(s) of expression of the V2R in the mouse by expression of the reporter gene beta-galactosidase introduced in the V2R gene by homologous recombination.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK041244-08
Application #
2391417
Study Section
Biochemical Endocrinology Study Section (BCE)
Program Officer
Sato, Sheryl M
Project Start
1989-12-15
Project End
1998-03-31
Budget Start
1997-07-15
Budget End
1998-03-31
Support Year
8
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Anesthesiology
Type
Schools of Medicine
DUNS #
119132785
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Gouill, Christian Le; Darden, Thomas; Madziva, Michael T et al. (2005) A role for K268 in V2R folding. FEBS Lett 579:4985-90
Innamorati, Giulio; Whang, Michael Insuk; Molteni, Raffaella et al. (2002) GIP, a G-protein-coupled receptor interacting protein. Regul Pept 109:173-9
Le Gouill, Christian; Innamorati, Giulio; Birnbaumer, Mariel (2002) An expanded V2 receptor retention signal. FEBS Lett 532:363-6
Innamorati, G; Le Gouill, C; Balamotis, M et al. (2001) The long and the short cycle. Alternative intracellular routes for trafficking of G-protein-coupled receptors. J Biol Chem 276:13096-103
Cilluffo, M C; Esqueda, E; Farahbakhsh, N A (2000) Multiple receptor activation elicits synergistic IP formation in nonpigmented ciliary body epithelial cells. Am J Physiol Cell Physiol 279:C734-43
Sadeghi, H; Birnbaumer, M (1999) O-Glycosylation of the V2 vasopressin receptor. Glycobiology 9:731-7
Boulay, G; Brown, D M; Qin, N et al. (1999) Modulation of Ca(2+) entry by polypeptides of the inositol 1,4, 5-trisphosphate receptor (IP3R) that bind transient receptor potential (TRP): evidence for roles of TRP and IP3R in store depletion-activated Ca(2+) entry. Proc Natl Acad Sci U S A 96:14955-60
Rajagopalan-Gupta, R M; Mukherjee, S; Zhu, X et al. (1999) Roles of Gi and Gq/11 in mediating desensitization of the luteinizing hormone/choriogonadotropin receptor in porcine ovarian follicular membranes. Endocrinology 140:1612-21
Sadeghi, H M; Innamorati, G; Esqueda, E et al. (1998) Processing and ligand-induced modifications of the V2 vasopressin receptor. Adv Exp Med Biol 449:339-46
Innamorati, G; Sadeghi, H M; Tran, N T et al. (1998) A serine cluster prevents recycling of the V2 vasopressin receptor. Proc Natl Acad Sci U S A 95:2222-6

Showing the most recent 10 out of 21 publications